Geriatric Cancer

Reduced-Intensity Chemotherapy for Frail Elderly Patients with Advanced Gastroesophageal Cancer

TOP - August 2019, Vol 12, No 3 - Geriatric Cancer

Reduced-dose chemotherapy is as effective as full-dose chemotherapy in frail elderly patients with advanced gastroesophageal cancer, according to results of the phase 3 GO2 clinical trial presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.

Results 1 - 1 of 1

To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".

I'd like to receive:

TOP Print Edition

TOP Weekly e‑Newsletter

I have reviewed and consent to the terms of TOP's Privacy Policy, and TOP has my permission to retain my information in its database, and to forward pertinent communications to me.